Fidelity Investments’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-448,539
| Closed | -$78.3K | – | 5694 |
|
|
2023
Q1 | $78.3K | Sell |
448,539
-4,157,054
| -90% | -$725K | ﹤0.01% | 3279 |
|
|
2022
Q4 | $1.83M | Buy |
4,605,593
+125,159
| +3% | +$49.8K | ﹤0.01% | 2399 |
|
|
2022
Q3 | $3.5M | Buy |
4,480,434
+1,106,420
| +33% | +$865K | ﹤0.01% | 2271 |
|
|
2022
Q2 | $9.72M | Buy |
3,374,014
+18,675
| +0.6% | +$53.8K | ﹤0.01% | 1977 |
|
|
2022
Q1 | $21M | Buy |
3,355,339
+477
| +0% | +$2.99K | ﹤0.01% | 1761 |
|
|
2021
Q4 | $37.4M | Buy |
3,354,862
+5,179
| +0.2% | +$57.7K | ﹤0.01% | 1545 |
|
|
2021
Q3 | $54.7M | Buy |
3,349,683
+43,101
| +1% | +$704K | ﹤0.01% | 1375 |
|
|
2021
Q2 | $61.3M | Buy |
3,306,582
+7,468
| +0.2% | +$138K | ﹤0.01% | 1341 |
|
|
2021
Q1 | $48.3M | Buy |
3,299,114
+483,963
| +17% | +$7.08M | ﹤0.01% | 1414 |
|
|
2020
Q4 | $84.7M | Buy |
+2,815,151
| New | +$84.7M | 0.01% | 1107 |
|